secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001140361-24-042968
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acasti Pharma redomiciles from Canada to Delaware effective October 7, 2024
---------------------------------------------------------------------------

- Changed jurisdiction from Quebec to British Columbia (Oct 1) and then to Delaware (Oct 7, 2024).
- Shareholders approved continuance and domestication at Sept 30, 2024 meeting.
- Rights of common stockholders now governed by Delaware General Corporation Law and new Charter/Bylaws.
- Entered into indemnification agreements with each executive officer and director.
- Common stock continues trading on Nasdaq under symbol ACST.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000114036124042968/0001140361-24-042968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000114036124042968/ef20036564_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-042968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer